Attached files
| file | filename |
|---|---|
| EX-31.2 - EX-31.2 - IDEAYA Biosciences, Inc. | idya-ex312_10.htm |
| EX-31.1 - EX-31.1 - IDEAYA Biosciences, Inc. | idya-ex311_7.htm |
| EX-10.3 - EX-10.3 - IDEAYA Biosciences, Inc. | idya-ex103_470.htm |
| 10-Q - 10-Q - IDEAYA Biosciences, Inc. | idya-10q_20200630.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Yujiro Hata, President and Chief Executive Officer of IDEAYA Biosciences, Inc. (the “Company”), hereby certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:
|
(1) |
The Quarterly Report on Form 10-Q of the Company for the period ended June 30, 2020 (the “Report”) fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and |
|
(2) |
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|
By: |
/s/ Yujiro Hata |
|
|
|
|
Yujiro Hata |
|
|
|
President and Chief Executive Officer |
|
|
|
(Principal Executive Officer) |
I, Paul Stone, J.D., Chief Financial Officer and General Counsel of IDEAYA Biosciences, Inc. (the “Company”), hereby certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:
|
(1) |
The Quarterly Report on Form 10-Q of the Company for the period ended June 30, 2020 (the “Report”) fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and |
|
(2) |
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|
Date: August 12, 2020 |
By: |
/s/ Paul Stone, J.D. |
|
|
|
Paul Stone, J.D. |
|
|
|
Chief Financial Officer |
|
|
|
(Principal Financial and Accounting Officer) |